| Product Code: ETC7657164 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Non-Hodgkin Lymphoma Diagnostics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Non-Hodgkin Lymphoma Diagnostics Market - Industry Life Cycle |
3.4 Israel Non-Hodgkin Lymphoma Diagnostics Market - Porter's Five Forces |
3.5 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
3.7 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F |
3.8 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.9 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Non-Hodgkin Lymphoma Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-Hodgkin lymphoma in Israel |
4.2.2 Technological advancements in diagnostic technologies |
4.2.3 Government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High costs associated with diagnostic procedures |
4.3.2 Limited access to advanced diagnostic facilities in certain regions of Israel |
5 Israel Non-Hodgkin Lymphoma Diagnostics Market Trends |
6 Israel Non-Hodgkin Lymphoma Diagnostics Market, By Types |
6.1 Israel Non-Hodgkin Lymphoma Diagnostics Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.4 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.1.5 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.6 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Biomarker Test, 2021- 2031F |
6.1.7 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Genetic Test, 2021- 2031F |
6.1.8 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Cytogenetics, 2021- 2031F |
6.1.9 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Non-Hodgkin Lymphoma Diagnostics Market, By Cancer Stage |
6.2.1 Overview and Analysis |
6.2.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage 0, 2021- 2031F |
6.2.3 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.4 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Ii, 2021- 2031F |
6.2.5 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Iii, 2021- 2031F |
6.2.6 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Iv, 2021- 2031F |
6.3 Israel Non-Hodgkin Lymphoma Diagnostics Market, By Tumor Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Aggressive Lymphomas, 2021- 2031F |
6.3.3 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Indolent Lymphomas, 2021- 2031F |
6.4 Israel Non-Hodgkin Lymphoma Diagnostics Market, By Product |
6.4.1 Overview and Analysis |
6.4.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Instrument Based Products, 2021- 2031F |
6.4.3 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Platform Based Products, 2021- 2031F |
6.4.4 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Kits And Reagents, 2021- 2031F |
6.4.5 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Other Consumables, 2021- 2031F |
6.5 Israel Non-Hodgkin Lymphoma Diagnostics Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Fluorescent In Situ Hybridization, 2021- 2031F |
6.5.3 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Next Generation Sequencing, 2021- 2031F |
6.5.4 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Fluorimmunoassay, 2021- 2031F |
6.5.5 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Comparative Genomic Hybridization, 2021- 2031F |
6.5.6 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Immunohistochemical, 2021- 2031F |
6.5.7 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Non-Hodgkin Lymphoma Diagnostics Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Screening, 2021- 2031F |
6.6.3 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Diagnostic And Predictive, 2021- 2031F |
6.6.4 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Prognostic, 2021- 2031F |
6.6.5 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Research, 2021- 2031F |
6.7 Israel Non-Hodgkin Lymphoma Diagnostics Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.7.4 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.7.5 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.7.6 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.7.7 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.8 Israel Non-Hodgkin Lymphoma Diagnostics Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.8.3 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Retail Sales, 2021- 2031F |
6.8.4 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By , 2021- 2031F |
7 Israel Non-Hodgkin Lymphoma Diagnostics Market Import-Export Trade Statistics |
7.1 Israel Non-Hodgkin Lymphoma Diagnostics Market Export to Major Countries |
7.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Imports from Major Countries |
8 Israel Non-Hodgkin Lymphoma Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of new diagnostic technologies in the market |
8.2 Percentage of non-Hodgkin lymphoma cases diagnosed at an early stage |
8.3 Average waiting time for diagnostic test results |
9 Israel Non-Hodgkin Lymphoma Diagnostics Market - Opportunity Assessment |
9.1 Israel Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Cancer Stage, 2021 & 2031F |
9.3 Israel Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Tumor Type, 2021 & 2031F |
9.4 Israel Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.5 Israel Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.6 Israel Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Israel Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Israel Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Non-Hodgkin Lymphoma Diagnostics Market - Competitive Landscape |
10.1 Israel Non-Hodgkin Lymphoma Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Israel Non-Hodgkin Lymphoma Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here